Feature Channels: Respiratory Diseases and Disorders

• share
• favorite_border

UAB experts provide tips for you to prepare yourself in the event of the spread of COVID-19.

• share
• favorite_border

Led by Tony Hu, the Weatherhead Presidential Chair in Biotechnology Innovation at Tulane University School of Medicine, researchers are now developing a rapid, reliable and highly specific test to allow rapid diagnosis of all forms of Tuberculosis (TB).

• share
• favorite_border

A study by the American Academy of Sleep Medicine found that while approximately 30 million American adults have obstructive sleep apnea only about 6 million, or 20%, have been properly diagnosed and treated.

• share
• favorite_border

The ATS Foundation Research Program and the American Lung Association have awarded Donald Sullivan, MD, of Oregon Health & Science University a $100,000 Foundation Partner grant. The ATS Foundation Partner Grants provide crucial support to talented investigators from around the world, launching careers dedicated to scientific discovery and better patient care.

• share
• favorite_border

The American Thoracic Society will host the world’s leading scientists and clinicians in pulmonary, critical care, and sleep medicine at the ATS 2020 International Conference (ATS 2020).

• share
• favorite_border

Doctors who use drugs that target antibiotic-resistant bacteria as a first-line defense against pneumonia should probably reconsider this approach, according to a new study of more than 88,000 veterans hospitalized with the disease. The study found that pneumonia patients given these medications in the first few days after hospitalization fared no better than those receiving standard medical care for the condition.

• share
• favorite_border

Findings from CT scans provide new insight that could lead to quicker diagnosis

• share
• favorite_border

Researchers reporting in ACS’ Environmental Science & Technology have compared PFAS in the serum of female firefighters and female office workers, finding higher levels of three compounds in the firefighters.

• share
• favorite_border

• share
• favorite_border

As of Feb. 25, 2020, the World Health Organization reported 79,339 confirmed cases of novel coronavirus, also known as COVID-19. Thirty-four countries have reported cases, including 2,619 deaths.The WHO has not declared COVID-19 as a pandemic — a situation defined somewhat vaguely by the WHO as “the worldwide spread of a new disease.

• share
• favorite_border

• share
• favorite_border

Harvard University scientists will collaborate with Chinese colleagues to elucidate the basic biology of the novel coronavirus (COVID-19), and the resulting disease, toward new diagnostic tools, vaccine development and antiviral therapies. The collaboration is part of a $115 million research initiative funded by China Evergrande Group.

• share
• favorite_border

Experts believe that tuberculosis, or TB, has been a scourge for humans for some 15,000 years, with the first medical documentation of the disease coming out of India around 1000 B.C.E. Today, the World Health Organization reports that TB is still the leading cause of death worldwide from a single infectious agent, responsible for some 1.5 million fatalities annually. Primary treatment for TB for the past 50 years has remained unchanged and still requires patients to take multiple drugs daily for at least six months. Successful treatment with these anti-TB drugs — taken orally or injected into the bloodstream — depends on the medications “finding their way” into pockets of TB bacteria buried deep within the lungs.

• share
• favorite_border

Traditional stoves that burn biomass materials and are not properly ventilated, which are widely used in developing nations where cooking is done indoors, have been shown to significantly increase indoor levels of harmful PM2.5 (miniscule atmospheric particulates) and carbon monoxide (CO) and to stimulate biological processes that cause lung inflammation and may lead to chronic obstructive pulmonary disease (COPD), according to new research published online in the Annals of the American Thoracic Society.

• share
• favorite_border

Research from Rutgers Cancer Institute of New Jersey shows administering the immunotherapy drug pembrolizumab together with chemotherapy given at the same time as radiation treatment (chemoradiation) is safe and tolerable as a first-line therapy for patients with stage 3 non-small cell lung cancer (NSCLC).

• share
• favorite_border

. Em um novo artigo publicado em 4 de fevereiro pela revista JAMA, os pesquisadores da Mayo Clinic descrevem os benefícios da terapia de ventilação não invasiva em casa, que exerce uma pressão positiva nas vias aéreas em dois níveis, ou BiPAP, para vários pacientes com doença pulmonar obstrutiva crônica (DPOC).

• share
• favorite_border

在2月4日JAMA发布的一篇新论文中，Mayo Clinic的研究人员描述了家庭无创通气治疗对许多慢性阻塞性肺疾病(COPD)患者的益处，其中包括一种被称为双水平气道正压(BiPAP)的治疗。 该团队确定了许多益处，包括降低死亡率、减少住院次数、降低插管风险、改善气短症状和减少急诊次数。

• share
• favorite_border

In einer neuen, am 4. Feb. in JAMA veröffentlichten Arbeit beschreiben Forscher von Mayo Clinic die Vorzüge einer nicht-invasiven Beatmungstherapie zu Hause ― die einen Typ umfasst, der auch als BiPAP bezeichnet wird ― für viele Patienten mit chronisch obstruktiver Lungenkrankheit (COPD).

• share
• favorite_border

Dans un nouvel article publié le 4 février dans JAMA, les chercheurs de Mayo Clinic décrivent les avantages de la thérapie de ventilation non invasive à domicile ; celle-ci comprend un dispositif appelé dispositif à pression positive biniveau, ou BiPAP, destiné à de nombreux patients atteints de bronchopneumopathie chronique obstructive (BPCO).